Avanos Medical, Inc. (AVNS) Tops Q3 EPS by 11c, Affirms FY Guidance

Avanos Medical, Inc. (NYSE: AVNS) reported Q3 EPS of $0.37, $0.11 better than the analyst estimate of $0.26. Revenue for the quarter came in at $165 million versus the consensus estimate of $166.66 million.

GUIDANCE:

Avanos Medical, Inc. sees FY2018 EPS of $1.75-$1.90, versus the consensus of $0.65.

For earnings history and earnings-related data on Avanos Medical, Inc. (AVNS) click here.

You May Also Be Interested In

• Wex, Inc. (WEX) Tops Q2 EPS by 29c; raises guidance
• Lake Shore Bancorp (LSBK) Tops Q2 EPS by 29c
• Chemung Financial (CHMG) Tops Q2 EPS by 5c